Application 125166

Type
BLA
Sponsor
ALEXION PHARM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SOLIRISECULIZUMABINJECTABLE; IV (INFUSION)300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25682-001SOLIRISECULIZUMABAlexion Pharmaceuticals Inc.BLACurrent
25682-001SOLIRISECULIZUMABAlexion Pharmaceuticals Inc.BLACurrent
25682-001SOLIRISECULIZUMABAlexion Pharmaceuticals Inc.BLACurrent
25682-001SOLIRISECULIZUMABAlexion Pharmaceuticals IBLACurrent
25682-001SOLIRISECULIZUMABAlexion Pharmaceuticals Inc.BLACurrent
25682-001SOLIRISECULIZUMABAlexion Pharmaceuticals Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82694SUPPL 2025-06-30
81420SUPPL 2025-03-04
81404SUPPL 2025-03-03
81387SUPPL 2025-03-03
79668SUPPL 2024-09-20
79665SUPPL 2024-09-20
78957SUPPL 2024-07-02
78947SUPPL 2024-07-01
78946SUPPL 2024-07-01
77950SUPPL 2024-03-25
77935SUPPL 2024-03-25
77445SUPPL 2024-02-09
77438SUPPL 2024-02-09
69510SUPPL2021-12-07
65825SUPPL2021-01-06
65465SUPPL2020-12-02
65298SUPPL2020-11-23
62481SUPPL2020-04-17
60083SUPPL2019-09-20
59197SUPPL2019-07-25
59198SUPPL2019-06-28
55061SUPPL2018-07-31
55010SUPPL2018-07-26
55009SUPPL2018-07-26
54992SUPPL2018-07-26
54991SUPPL2018-07-26
52819SUPPL2018-03-06
52786SUPPL2018-03-01
50153SUPPL2017-10-24
50146SUPPL2017-10-23
46898SUPPL2017-01-19
46861SUPPL2017-01-13
31867SUPPL2016-04-15
31866SUPPL2015-12-08
18825SUPPL2015-12-08
9649SUPPL2015-12-08
43309SUPPL2015-07-20
9648SUPPL2014-10-14
39874SUPPL2014-05-02
18824SUPPL2014-05-02
9647SUPPL2014-05-02
9646SUPPL2014-05-02
31865SUPPL2012-12-27
18823SUPPL2011-09-23
24084ORIG2010-06-30
9645SUPPL2010-06-29
9644SUPPL2009-08-07
43308ORIG2007-05-17
31864ORIG2007-03-27
39873ORIG2007-03-23